Nanoparticles as Drug Delivery Systems 


Vol. 69,  No. 4, pp. 184-187, Aug.  2025
10.5012/jkcs.2025.69.4.184


PDF JATS XML
  Abstract

Two different hollow porous inorganic polymers, SiO nanoparticle and TiO nanoparticle were produced to examine their possibility as delivery systems of two peptide drugs, glucagon-like peptide-1 (Glp-1) and enfuvirtide (ENF) in this work. Specifically, their encapsulation in hollow porous silica nanoparticles (HPSNs) and their release from HPSNs were investigated. HPSNs are capable of loading Glp-1 and ENF and they are released from HPSNs by roughly 10%. Our results represent that HPSNs are promising candidates for preservation of Glp-1 and ENF from biodegradability and for their long time release. And how much hollow porous nanoparticles (HPNs) affect the hair growth of minoxidil was also investigated. It appears that both HPSNs and hollow porous TiO nanoparticles enhance the hair growth effect of minoxidil.

  Statistics
Cumulative Counts from November, 2022
Multiple requests among the same browser session are counted as one view. If you mouse over a chart, the values of data points will be shown.


  Cite this article

[IEEE Style]

B. Cho, "Nanoparticles as Drug Delivery Systems," Journal of the Korean Chemical Society, vol. 69, no. 4, pp. 184-187, 2025. DOI: 10.5012/jkcs.2025.69.4.184.

[ACM Style]

Bongrae Cho. 2025. Nanoparticles as Drug Delivery Systems. Journal of the Korean Chemical Society, 69, 4, (2025), 184-187. DOI: 10.5012/jkcs.2025.69.4.184.